Want to see IT:FDA full AI Analyst Report?
Top Page
Fidia Spa
(FDA)
Select Model
Select Model
Rating:43Neutral
Price Target:
€0.01
▼(-91.67% Downside)
Action:Reiterated
Date:06/16/26
The score is primarily held down by weak recent cash flow (negative operating and free cash flow in 2023–2025) and inconsistent operating profitability, despite a sharp 2025 revenue rebound and an improved balance sheet. Technical signals are unavailable (neutral impact), and valuation signals are limited by a negative P/E and no dividend yield data.
Positive Factors
Revenue Recovery
The sharp 2025 rebound indicates recovering demand and renewed commercial traction. Sustaining this higher revenue base could improve operating leverage, broaden funding capacity, and support investment in products and geographic expansion.
Negative Factors
Persistent Cash Burn
Three consecutive years of negative operating and free cash flow weaken self-funding capacity. Unless working capital and profitability improve, Fidia may need additional financing, asset sales, or tighter investment to sustain operations.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Recovery
The sharp 2025 rebound indicates recovering demand and renewed commercial traction. Sustaining this higher revenue base could improve operating leverage, broaden funding capacity, and support investment in products and geographic expansion.
Read all positive factors
Fidia Spa (FDA) vs. iShares MSCI Italy ETF (EWI)
Market Cap
€9.75M
Dividend YieldN/A
Average Volume (3M)597.93K
Price to Earnings (P/E)―
Beta (1Y)0.95
Revenue Growth74.59%
EPS GrowthN/A
CountryIT
Employees146
SectorHealthcare
Sector Strength45
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,249,412,000
10 Day Avg. Volume275,058
30 Day Avg. Volume597,935
Financial Highlights & Ratios
PEG Ratio-0.17
Price to Book (P/B)2.28
Price to Sales (P/S)0.60
P/FCF Ratio-4.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Fidia Spa Business Overview & Revenue Model
Company Description
Fidia S.p.A., together with its affiliated entities, focuses on engineering, producing, and supplying advanced high-speed milling systems and computerized numerical control (CNC) machines. Their product range also incorporates specialized milling ...
How the Company Makes Money
Fidia makes money primarily by selling its healthcare products (including hyaluronic-acid–based products and other pharmaceutical/medical products) to customers in its served markets. Revenue is generated through (1) direct sales where Fidia marke...
Fidia Spa Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
52
Neutral
Cash Flow
28
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 30.53M | 17.49M | 28.61M | 24.37M | 23.84M |
| Gross Profit | 7.38M | 12.97M | 19.13M | 1.45M | 15.53M |
| EBITDA | -635.00K | -7.66M | 667.00K | 7.63M | -888.00K |
| Net Income | 1.04M | -9.30M | -1.31M | 5.97M | -3.50M |
Balance Sheet | |||||
| Total Assets | 26.34M | 28.30M | 32.17M | 32.13M | 40.47M |
| Cash, Cash Equivalents and Short-Term Investments | 2.44M | 1.67M | 3.17M | 4.87M | 5.27M |
| Total Debt | 5.24M | 1.01M | 11.44M | 8.26M | 11.68M |
| Total Liabilities | 18.28M | 25.35M | 28.74M | 4.55M | 42.21M |
| Stockholders Equity | 8.07M | 2.94M | 3.22M | 5.97M | -2.33M |
Cash Flow | |||||
| Free Cash Flow | -4.06M | -4.45M | -5.31M | 495.00K | 498.00K |
| Operating Cash Flow | -3.63M | -4.34M | -4.84M | 793.00K | 584.00K |
| Investing Cash Flow | 648.00K | -47.00K | -357.00K | -231.00K | -57.00K |
| Financing Cash Flow | 4.55M | 2.44M | 3.43M | 747.00K | -1.09M |
Fidia Spa Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | €3.94B | 18.41 | 10.05% | 1.02% | 0.99% | -0.11% | |
56 Neutral | €228.97M | 108.71 | 0.07% | ― | 12.03% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | €147.70M | -6.99 | -10.66% | ― | -4.54% | -75.92% | |
43 Neutral | €9.75M | -0.29 | 17.04% | ― | 74.59% | ― |
* Healthcare Sector Average
IT:FDA
Fidia Spa
0.01
-0.27
-96.45%
IT:BSS
Biesse SPA
5.39
-2.32
-30.09%
IT:IP
Interpump Group SPA
37.00
-3.79
-9.30%
IT:TES
Tesmec S.p.A.
0.38
0.29
313.04%
IT:ESAU
Esautomotion SpA
3.80
0.46
13.77%
IT:MARP
Marzocchi Pompe S.p.A.
2.20
-0.41
-15.64%
Fidia Spa Corporate Events
Fidia Issues Formal Correction to 2025 Governance Report
Aug 5, 2026
Fidia S.p.A. has issued a corrected version of its 2025 report on corporate governance and ownership structure, prepared under Italian financial regulations, after identifying a typographical error in the table describing its Board of Directors. T...
Fidia Details June Financial Position and Impact of Convertible Bond Financing
Jul 31, 2026
Fidia S.p.A. has released its June 2026 monthly financial update in compliance with CONSOB’s enhanced disclosure regime under Article 114 of the Italian TUF, detailing net financial position, overdue debts and related-party changes. The comp...
Fidia Discloses May 2026 Net Debt Under Enhanced CONSOB Transparency Rules
Jun 30, 2026
Fidia S.p.A. reported its net financial position for 31 May 2026 under CONSOB‑mandated monthly disclosure, showing liquidity of €845,000 against current financial indebtedness of €4.877 million and net current financial indebtedn...
Fidia returns to profit and renews governance as shareholders back 2025 accounts
Jun 29, 2026
Fidia S.p.A. reported a sharp turnaround in its 2025 results, with standalone revenues more than doubling to €21 million and a return to a net profit of €345,000 after a heavy loss a year earlier. The group’s consolidated revenue...
Fidia investor trims stake after crossing takeover threshold
Jun 22, 2026
Fidia S.p.A. disclosed that shareholder Global Growth Holding Limited has crossed a regulatory shareholding threshold after converting a previously subscribed convertible bond into equity. GGHL stressed that the increase stems solely from the fina...
Fidia Completes €5 Million Convertible Bond Program to Fund Potential Sector Acquisition
Jun 10, 2026
Fidia has completed the subscription and immediate conversion of the remaining 200 bonds under its 2026 convertible bond program with attached warrants, raising a total nominal €2 million in this final tranche and issuing 666,666,666 new sha...
Fidia Publishes Governance Slates Ahead of June Shareholders’ Meeting
Jun 8, 2026
Fidia S.p.A., a Turin-based provider of advanced numerical controls and high-performance integrated milling systems for automotive mould and aerospace applications, has received candidate slates for the upcoming renewal of its governance bodies. T...
Fidia’s Auditor Flags Going‑Concern Uncertainty in 2025 Accounts
Jun 8, 2026
Fidia has disclosed that its statutory auditor Deloitte Touche included a paragraph highlighting significant uncertainties about the company’s and group’s ability to continue as a going concern in the audit report on the 2025 Annual F...
Fidia Publishes 2025 Annual Report and Governance Documents
Jun 5, 2026
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global leader in numerical control systems and integrated high‑performance milling solutions for complex shapes, focusing on moulds for the automotive industry and applications ...
Fidia opens window for minority lists in Board of Statutory Auditors vote
Jun 5, 2026
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global leader in high-performance integrated milling systems, numerical controls and CAM software for complex shapes serving automotive mould and aerospace customers. With more than f...
Fidia completes twelfth‑tranche POC bond conversion, boosting share capital
Jun 1, 2026
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global player in high‑performance integrated milling systems used mainly in automotive mould making and aerospace applications. With over five decades of experience and around 1...
Fidia Reports April 2026 Net Financial Position Under CONSOB Oversight
May 29, 2026
Fidia S.p.A. has released its mandated monthly financial update for April 2026, detailing its net financial position at both company and group level, with a breakdown between short‑term and medium‑ to long‑term components. The di...
Fidia Advances €3 Million Convertible Bond Programme with New Tranche to GGHL
May 28, 2026
Fidia has issued the twelfth tranche of its 2026 convertible bond loan reserved for Global Growth Holding Limited, placing 25 bonds for a nominal total of €250,000 that have been fully subscribed and paid in. Alongside the bonds, the company...
Fidia Boosts Share Capital After Full Conversion of Convertible Bonds
May 28, 2026
Fidia has announced a significant change in its share capital following the conversion of a previously approved convertible bond loan into ordinary shares. Between 15 and 26 May 2026, bondholders converted a total nominal amount of €840,000 ...
Fidia completes bond conversion, issues 40 million new shares
May 26, 2026
Fidia S.p.A. has received a request from Global Growth Holding Limited to convert 12 bonds from the eleventh tranche of its reserved convertible bond loan, resulting in the issuance of 40,000,000 new shares at a conversion price of €0.003 pe...
Fidia Advances Recapitalization as GGHL Converts New Tranche of Convertible Bonds
May 25, 2026
Fidia has issued and fully placed the eleventh tranche of its reserved convertible bond loan with warrants to Global Growth Holding Limited, consisting of 25 bonds for a nominal €250,000 and 27,777,777 attached warrants exercisable into new ...
Fidia Boosts Capital as GGHL Converts Final Tranche of POC Bonds
May 22, 2026
Fidia S.p.A. has completed the tenth tranche of its reserved POC convertible bond loan with Global Growth Holding Limited, which subscribed 25 bonds for a nominal €250,000, fully paid in cash, and received 35,714,285 attached warrants exerci...
Fidia convenes June 2026 shareholder meeting to approve 2025 accounts and renew governance
May 21, 2026
Fidia has convened an ordinary shareholders’ meeting for 29 June 2026 in Turin to approve its 2025 standalone and consolidated financial statements and decide on the allocation of profit for the year. Shareholders will also vote on the 2026 ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.